News · 26 weeks29+75%
2026-03-012026-08-23
Mix1190d
- SEC Filings4(36%)
- Earnings2(18%)
- Leadership2(18%)
- Insider2(18%)
- Other1(9%)
Latest news
25 items- SECAzenta Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Azenta, Inc. (0000933974) (Filer)
- PRAZENTA ANNOUNCES LEADERSHIP TRANSITIONCurrent Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.Dr. Madaus has served in multiple CEO roles in the diagnostics and life science tools industry and joined the Azenta Board in 2024 – making him the ideal individual to lead the Company during this transition. He is a Senior O
- INSIDERSVP and CHRO Pirogova Olga covered exercise/tax liability with 1,085 units of Common, decreasing direct ownership by 3% to 31,953 units (SEC Form 4) (tax withholding)4 - Azenta, Inc. (0000933974) (Issuer)
- SECSEC Form 10-Q filed by Azenta Inc.10-Q - Azenta, Inc. (0000933974) (Filer)
- INSIDERSVP, Gen Counsel & Secretary Starr Ephraim bought $8,096 worth of Common (335 units at $24.17), increasing direct ownership by 0.49% to 68,728 units (SEC Form 4)4 - Azenta, Inc. (0000933974) (Issuer)
- SECAzenta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Azenta, Inc. (0000933974) (Filer)
- PRAzenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.BURLINGTON, Mass., Aug. 4, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2026. The results of B Medical Systems are reported as discontinued operations and reflected in total diluted EPS. The Company entered into a definitive agreement to sell the business during fiscal 2025, and the transaction closed on July 1, 2026, on the terms described in the Company's Current Report on Form 8-K filed on July 8, 2026. Quarter EndedDollars in millions, except per share dataJune 30,March 31,June 30,Change202620262025(1)Prior QtrPrior Yr.Revenue from Continuing Operations$ 161$ 145$ 14411 %12 %Organic growth9 %Sampl
- PRCabot Corporation Announces Planned Leadership TransitionBOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that Sean Keohane has notified the Board of Directors of his decision to retire as President and Chief Executive Officer (CEO) of the Company and to step down from the Company’s Board of Directors, each effective September 30, 2026. Erica McLaughlin, Executive Vice President, Chief Financial Officer (CFO) and Head of Corporate Strategy, has been elected to succeed Keohane as President and CEO, and to serve on the Board as a member of the class of directors whose term expires at the 2029 Annual Meeting of Stockholders, both effective October 1, 2026. Keohane will remain with the Company in an advisory ca
- PRAzenta Announces Fiscal 2026 Third Quarter Conference Call and WebcastBURLINGTON, Mass., July 22, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.The Company will host a conference call and live webcast to discuss its financial results the following day, Wednesday, August 5, 2026, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on August 6, 2026.About Azenta Life SciencesAzenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling i
- SECAzenta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Azenta, Inc. (0000933974) (Filer)
- PRAzenta Completes Sale of B Medical SystemsBURLINGTON, Mass., July 8, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.à r.l.The transaction was originally announced on December 29, 2025 and closed on July 1, 2026 following the satisfaction of all closing conditions. Under the terms of the agreement, Azenta sold B Medical Systems for a fixed purchase price of $63 million in cash, of which $35 million was funded through a short-term secured vendor loan from an Azenta subsidiary to Thelema. Additional details regarding the transaction are available in the Company's Current Report on Form 8-K filed with the Securities and Exchan
- SECSEC Form SD filed by Azenta Inc.SD - Azenta, Inc. (0000933974) (Filer)
- PRAzenta Publishes 2025 Environmental, Social, and Governance (ESG) ReportBURLINGTON, Mass., May 21, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2025.The report offers a comprehensive overview of the Company's ESG approach, highlighting achievements across three core pillars:Environmental Protection: We understand the broad scope of our operations and are committed to reducing our environmental impact while continuing to expand our business.Social Impact: We are committed to making a positive impact on society, particularl
- INSIDERDirector Cornog William L bought $163,800 worth of Common (10,000 units at $16.38) (SEC Form 4)4 - Azenta, Inc. (0000933974) (Issuer)
- INSIDERSVP, Gen Counsel & Secretary Starr Ephraim covered exercise/tax liability with 3,621 units of Common, decreasing direct ownership by 5% to 68,393 units (SEC Form 4) (for tax liability)4 - Azenta, Inc. (0000933974) (Issuer)
- INSIDERDirector Koffey Quentin was granted 5,663 shares, increasing direct ownership by 112% to 10,698 units (SEC Form 4)4 - Azenta, Inc. (0000933974) (Issuer)
- SECSEC Form S-8 filed by Azenta Inc.S-8 - Azenta, Inc. (0000933974) (Filer)
- SECSEC Form 10-Q filed by Azenta Inc.10-Q - Azenta, Inc. (0000933974) (Filer)
- SECAzenta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Azenta, Inc. (0000933974) (Filer)
- PRAzenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029FY'26 total reported revenue from continuing operations to range between approximately $603 to $621 millionFY'26 organic revenue is now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growthFY'26 Adjusted EBITDA margin is now expected to range from down approximately 125 basis points to flat, compared to prior expectations of approximately 300 basis points of expansionLong-range plan timing updated to 2029 versus 2028 before in connection with revised 2026 guidance. Market opportunities, strategic priorities, and value creation framework remain intact.BURLINGTON, Mass., May 5, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financi
- INSIDERPresident Multiomics Martin William E. Iii was granted 17,790 units of Common (SEC Form 4)4 - Azenta, Inc. (0000933974) (Issuer)
- PRAzenta Announces Fiscal 2026 Second Quarter Conference Call and WebcastBURLINGTON, Mass., April 29, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal second quarter 2026 earnings which ended on March 31, 2026, on Wednesday, May 6, 2026, before the market opens.The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on May 7, 2026.About Azenta Life SciencesAzenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactf
- INSIDERSEC Form 3 filed by new insider Martin William E. Iii3 - Azenta, Inc. (0000933974) (Issuer)
- SECAzenta Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Azenta, Inc. (0000933974) (Filer)
- PRAzenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics ExecutionBURLINGTON, Mass., April 7, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead the Multiomics organization and report to John Marotta, Azenta's President and Chief Executive Officer.This appointment is aimed at accelerating execution of Azenta's Multiomics long-range plan, outlined at its December 2025 Investor Day, with a continued focus on scaling global synthesis capabilities, strengthening operational excellence, enhancing commercial discipline, and driving profitable growth across the integrated Multiomics platform to support broader market ado
AZTA FAQ
6 questionsWhat does Azenta Inc. do?
Azenta, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates. The Life Sciences Services segment offers genomic services and...Where does AZTA stock trade?
Azenta Inc. (AZTA) is listed on NASDAQ.What sector and industry is AZTA in?
Azenta Inc. operates in the Technology sector, Industrial Machinery/Components industry.What are analysts saying about AZTA?
Azenta Inc. has had 8 recent analyst actions on file. The most recent action was from Evercore ISI: Outperform on 2026-01-05. Recent price targets range from $3500.00 to $4400.00.What companies are similar to AZTA?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare AZTA side-by-side with any of them on Quantisnow.How can I track AZTA on Quantisnow?
Quantisnow aggregates Azenta Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AZTA to receive live email and push alerts on every new disclosure.